Ordering
Available Variants5 mg
CHA.30649-5mg
Price
€80.00
Available – Dispatch in 14 days
25 mg
CHA.30649-25mg
Price
€355.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.30649-5mg | €80.00 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.30649-25mg | €355.20 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C13H13N3S |
|---|---|
| CAS Number | 256922-53-9 |
| Molecular Weight | 243.33 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| MDL number | MFCD09998898 |
| Assay | ≥98% (HPLC) |
| Form | powder |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
CL075, also known by its CAS number 256922-53-9, is a synthetic compound that has garnered significant attention in the scientific community due to its unique properties and potential applications. As a selective agonist of the peroxisome proliferator-activated receptor gamma, CL075 has been investigated for its therapeutic potential in various diseases, including inflammatory disorders and cancer. Research has demonstrated that CL075 exhibits anti-inflammatory effects by modulating the expression of specific genes involved in the inflammatory response. Additionally, studies have shown that CL075 can induce apoptosis in cancer cells, suggesting its potential as a novel anticancer agent. Further research is necessary to fully elucidate the mechanisms of action and potential therapeutic applications of CL075, but its initial promise warrants continued investigation and exploration. Its chemical structure and properties make it an interesting candidate for further study.
